SavedAdd your journal

Journals / TSK Koruyucu Hekimlik Bülteni / 2009 / Cilt: 8 - Sayı: 1

One of the major problems in tuberculosis control: Adherence to therapy

Tüberküloz kontrolünde başlıca sorunlardan biri: Tedaviye uyum

Bergüzar KARA
Pages
75–82
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This article reviews evidence regarding adherence to TB treatment in patients and affecting factors and makes recommendations for health care professionals.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Abstract: Although tuberculosis (TB) is a preventable and curable disease, approximately one third of the world’s population is infected with the TB bacillus.
📊
Key Findings & Data:It is estimated that the rate of nonadherence to TB treatment ranges from 20 to 80%.
💡
Conclusion & Impact:This article reviews evidence regarding adherence to TB treatment in patients and affecting factors and makes recommendations for health care professionals.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Abstract: Although tuberculosis (TB) is a preventable and curable disease, approximately one third of the world’s population is infected with the TB bacillus. Tuberculosis is a major public health problem in especially developing countries. Nonadherence to TB therapy regimes is common, as treatment is difficult and requires long courses of multiple antibiotics. It is estimated that the rate of nonadherence to TB treatment ranges from 20 to 80%. Nonadherence to TB treatment is the most serious barrier in disease control because incomplete treatment may result in prolonged infectiousness, drug resistance, relapse and death. However, handling the factors affecting adherence to treatment for the patients may increase the efficiency of the treatment and help to reach better health outcomes. This article reviews evidence regarding adherence to TB treatment in patients and affecting factors and makes recommendations for health care professionals.

Özet

Tüberküloz (TB) önlenebilen ve tedavi edilebilen bir hastalık olmasına karşın, dünya nüfusunun yaklaşık üçte biri TB basili ile enfektedir. TB, özellikle gelişmekte olan ülkelerde önemli bir halk sağlığı sorunudur. Tedavinin güç olması ve birçok antibiyotiğin uzun süre kullanılması nedeniyle TB tedavi programına uyumsuzluk yaygındır. TB tedavisine uyumsuzluk sıklığının %20 ile %80 aralığında yer aldığı tahmin edilmektedir. TB tedavisine uyumsuzluk, hastalığın kontrolünde en ciddi engeldir. Çünkü tamamlanmayan tedavi enfeksiyon sürecinin uzamasına, ilaç direncine, hastalığın tekrarına ve ölüme yol açabilmektedir. Bununla birlikte, hastaların tedaviye uyumunu etkileyen faktörlerin ele alınması, tedavinin etkinliğini artırabilir ve daha iyi sağlık sonuçlarına ulaşmaya yardım edebilir. Bu derlemede, hastalarda TB tedavisine uyum ve etkileyen faktörlerle ilgili kanıtlar gözden geçirilmekte ve sağlık personellerine önerilerde bulunulmaktadır.

🔖

Cite This Article

KARA, B. (2009). One of the major problems in tuberculosis control: Adherence to therapy. TSK Koruyucu Hekimlik Bülteni, Cilt: 8 - Sayı: 1, 75–82. https://ajindex.com/articles/131562

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Caceres Fde M, Orozco LC. Incidence of and factors for non-compliance to antituberculous treatment. Biomedica. 2007; 27(4): 498-504
  2. Ailinger RL, Moore JB, Nguyen N, Lasus H. Adherence to latent tuberculosis infection therapy among latino immigrants. Public Health Nurs. 2006; 23(4): 307-13
  3. Kılıçaslan Z. Dünyada ve Türkiye’de tüberküloz. ANKEM Dergisi. 2007; 21(Ek 2): 76-80
  4. Piersimoni C, Scarparo C. Pulmonary infections associated with non-tuberculous mycobacteria in immunocompetent patients. Lancet Infect Dis. 2008; 8(5): 323-34
  5. World Health Organization (WHO). 2008. Global tuberculosis control: surveillance, planning, financing._WHO_report,_Geneva._(WHO/HTM/T B/2008.393)._http://www.who.int/tb/publications/g lobal_report_[Erişim_Tarihi:_01.09.2008]
  6. Başoğlu ÖK, Atasever A. İzmir ili verem savaşı dispanserlerinde latent tüberküloz enfeksiyonu tedavisi. Akciğer Arşivi. 2005; 1: 14-8
  7. World Health Organization Regional Office for Europe. Basic statistics from the tuberculosis database:_Turkey._2004.http://www.euro.who.int/ tuberculosis/ctryinfo/_DatabaseExtraction?Countr y=TUR [Erişim tarihi: 01.09.2008]. 8._World_Health_Organization._Core_Health_Indicat ors._2006._http://www.who.int/whosis/database/c ore/core_select_process.cfm?countries=tur&indic ators=TBIncidenceRate&indicators=TBPrevRate [Erişim tarihi: 01.09.2008]
  8. Balbay O, Annakkaya AN, Arbak P, Bilgin C, Erbaş M. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the Northwest part of Turkey. Jpn J Infect Dis. 2005; 58: 152-8
  9. Escott S, Walley J. Listening to those on the frontline: lessons for community-based tuberculosis programmes from a qualitative study in Swaziland. Soc Sci Med. 2005; 61(8): 1701-10
  10. Jakubowiak WM, Bogorodskaya EM, Borisov SE, Danilova ID, Lomakina OB, Kourbatova EV. Social support and incentives programme for patients with tuberculosis: experience from the Russian Federation. Int J Tuberc Lung Dis. 2007; 11(11): 1210-5
  11. Kara İH. Tüberküloz: güncel epidemiyoloji ve hastalık yönetimi. Türk Aile Hek Derg 2007; 11(1): 33-42
  12. World Health Organization. Tuberculosis country profile:_Turkey._2006._http://www.who.int/Global Atlas/predefinedReports/TB/PDF_Files/tur.pdf [Erişim tarihi: 01.09.2008]
  13. Bao QS, Du YH, Lu CY. Treatment outcome of new pulmonary tuberculosis in Guangzhou, China 1993-2002: a register-based cohort study. BMC Public Health. 2007; 7: 344
  14. Rocha M, Pereira S, Ferreira L, Barros H